Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review

Ejemplares similares

• Commentary on Gregory et al .: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation
  por: Sandra A. Springer
  Publicado: (2024)
• Characteristics of deaths due to drug‐related causes among individuals recently released from prison in the United Kingdom, 1997–2025
  por: Emmert Roberts, et al.
  Publicado: (2026)
• A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine
  por: Charles Deng, et al.
  Publicado: (2025)
• Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA
  por: Gary J. Young, et al.
  Publicado: (2024)
• Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine
  por: Julia D’Agata Mount, et al.
  Publicado: (2024)